You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.
23andMe customers who have one of three common variants identified in reports can choose six family members to receive health and ancestry test kits.
CNBC reports that 23andMe is piloting a new program to incorporate customers' medical histories and lab tests with their genetic data.
Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.
NatGeo will continue to conduct research using its database, which includes data on roughly a million individuals.
The Israeli online genealogy company recently expanded its ancestry genetic testing offering to include health information.
23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
Consumer genomics companies have endeavored to reach out to minority communities with sometimes contentious results.
In 125,000 de-identified Invitae customers with and without a personal or family history of cancer, 23andMe's DTC test would have missed almost 90 percent of BRCA mutations.
The AP's Candace Choi writes that the diet and nutrition advice she received from two direct-to-consumer genetic testing firms was broad.
Nature News writes that viral genomic surveillance in the US faces systemic issues.
President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.
A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.
In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.